The latest innovations in lung cancer treatment
“Lung cancer is the most common type of cancer worldwide. Around 240,000 new cases will be diagnosed in the United States this year, mostly among smokers. A growing number of cases are being found in people who never smoked, which means factors like the environment or genetics may be involved.”
Collaboration to improve lung cancer screening for Blacks led by UAH nursing graduate student
“A Huntsville Hospital project to determine and overcome barriers to lung cancer screening participation experienced by African Americans is being led by a University of Alabama in Huntsville (UAH) graduate student who is pursuing her doctor of nursing practice (DNP) degree at UAH, a part of the University of Alabama System.”
Lung Cancer Research Foundation Announces 2022 Scientific Research Grant Awards
“The Lung Cancer Research Foundation® (LCRF) is pleased to announce the awardees of its 2022 Scientific Grant Program. This years’ grant cycle includes three new areas of funding in addition to its Pilot grants: LCRF Research Grant on Early Detection and Pre-Neoplasia in Lung Cancer, LCRF Research Grants on Oncogenic Drivers in Lung Cancer, and the newly launched LCRF Minority Career Development Award (CDA) for Lung Cancer. In partnership with ALK Positive, a separate request for proposals was introduced for the 2022 funding cycle.”
59-Year-Old Woman’s Unexplained Weight Loss Turned Out To Be Lung Cancer But She Never Smoked
“Diana Wei, a 59-year-old woman who never smoked a day in her life, was diagnosed with lung cancer after losing five pounds unexpectedly, and then another 13 pounds six months later.”
Lung Cancer in Nonsmokers: Statistics and Risk Factors
“About 10–20% of lung cancer cases in the United States occur in people who have never smoked. Risk factors for nonsmokers include secondhand smoke, radon gas, and air pollution.”
Avera medical oncologist leads promising effort to treat lung cancer
“Could a targeted three-drug combination help prolong the lives of patients who have a deadly form of advanced lung cancer? The SPRING trial sought to answer that question, and the final results show promise.”
Mirati reports initial data from lung cancer trials
Grade 1-2, Grade 3, and Grade 4 treatment-related adverse events were reported in the trial.
“Mirati Therapeutics has reported initial data from the Phase II KRYSTAL-7 clinical trial and KRYSTAL-1 Phase Ib cohort analysing a 400mg twice daily dose of adagrasib plus pembrolizumab to treat first-line non-small cell lung cancer (NSCLC) patients.”
Lovly receives Asclepios Award from GO2 for Lung Cancer
“The GO2 Foundation for Lung Cancer has recognized Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research and associate professor of Medicine, with the 2022 Asclepios Award, which recognizes lung cancer research pioneers.”
Novel Mechanisms of Action Open Door for New Drugs in Non–Small Cell Lung Cancer
“Future research should investigate which therapies with new mechanisms of action add incremental benefit to existing treatment regimens for non-small cell lung cancer.”
‘Game-Changing’ Lung Cancer Detection and Biopsy Technology Comes to Olympia
“Hoodsport’s Jean Pescar, 80, was feeling great at her last routine doctor’s appointment in October. She did, however, remember to mention one thing. When she broke her knee back in 2015, her doctor detected on the CT scan a small nodule on her lung. They monitored it for growth, but when Jean changed doctors a few years later, she forgot about it for a while.”
Video:
Dr. Patel on Key Updates from First-Line Trials in NSCLC
“Manish Patel, DO, hematologist, oncologist, associate professor of medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, discusses updates in treatment with a PD1 and CTLA-4 inhibitor in non–small cell lung cancer (NSCLC).”
Non–Small Cell Lung Cancer: Optimizing the Identification of KRAS G12C Mutations
“Shared insight on best practices in non–small cell lung cancer management to utilize molecular testing and identify patients harboring KRAS G12C mutations.”
Lung cancer patient, oncologist stress importance of early detection to save lives
CREVE COEUR (KMOV) – “Missourian Lucy Sheppard was first diagnosed with lung cancer nearly five years ago after getting a CT scan where doctors found a nodule.”
